Literature DB >> 25869401

Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?

Rémi Coudroy1, Angéline Jamet, Oscar Peñuelas, Arnaud W Thille.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25869401     DOI： 10.1007/s00134-015-3758-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Authors:  Kenneth P Steinberg; Leonard D Hudson; Richard B Goodman; Catherine Lee Hough; Paul N Lanken; Robert Hyzy; B Taylor Thompson; Marek Ancukiewicz
Journal:  N Engl J Med       Date:  2006-04-20       Impact factor: 91.245

2.  Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation.

Authors:  Jean-Marie Forel; Christophe Guervilly; Sami Hraiech; François Voillet; Guillemette Thomas; Claude Somma; Véronique Secq; Catherine Farnarier; Marie-Josée Payan; Stéphanie-Yannis Donati; Gilles Perrin; Delphine Trousse; Stéphanie Dizier; Laurent Chiche; Karine Baumstarck; Antoine Roch; Laurent Papazian
Journal:  Intensive Care Med       Date:  2014-10-30       Impact factor: 17.440

3.  Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management.

Authors:  Claude Guerin; Frédérique Bayle; Véronique Leray; Sophie Debord; Alina Stoian; Hodane Yonis; Jean-Baptiste Roudaut; Gael Bourdin; Mojgan Devouassoux-Shisheboran; Elodie Bucher; Louis Ayzac; Sylvie Lantuejoul; Carole Philipponnet; Jean Louis Kemeny; Bertrand Souweine; Jean-Christophe Richard
Journal:  Intensive Care Med       Date:  2014-12-05       Impact factor: 17.440

4.  Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies.

Authors:  Arnaud W Thille; Andrés Esteban; Pilar Fernández-Segoviano; José-María Rodriguez; José-Antonio Aramburu; Patricio Vargas-Errázuriz; Ana Martín-Pellicer; José A Lorente; Fernando Frutos-Vivar
Journal:  Lancet Respir Med       Date:  2013-05-15       Impact factor: 30.700

5.  Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

Authors:  G Umberto Meduri; Emmel Golden; Amado X Freire; Edwin Taylor; Muhammad Zaman; Stephanie J Carson; Mary Gibson; Reba Umberger
Journal:  Chest       Date:  2007-04       Impact factor: 9.410
  5 in total
  2 in total

1.  Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: yes.

Authors:  Thomas Bein; Josef Briegel; Djillali Annane
Journal:  Intensive Care Med       Date:  2016-02-16       Impact factor: 17.440

Review 2.  Weaning from Mechanical Ventilation in ARDS: Aspects to Think about for Better Understanding, Evaluation, and Management.

Authors:  Iuri Christmann Wawrzeniak; Silvia Regina Rios Vieira; Josué Almeida Victorino
Journal:  Biomed Res Int       Date:  2018-10-09       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.